Key facts
- Reagenics’s last known valuation is $3.5M (Oct 2022).
- It has raised $26.9M; the latest was Later Stage VC ($20.0M) in May 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Reagenics
- ·The full record, as it builds
Funding rounds
No funding rounds for Reagenics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Reagenics
Producer of plant molecular designed to grow and harvest organic plant molecules economically. The company provides technology that can grow living, organic plant molecules economically at scale without being dependent upon, or negatively impacting, environmental elements, including water, soil, weather, pollution, and pathogens.
- Sector
- Materials and Resources
- HQ
- Nes Tsiona, Israel
- Founded
- 2019
- Employees
- 9
- Website
- reagenics.com/
- Ownership
- Privately Held (backing)
Reagenics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Reagenics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Reagenics in its N-PORT filings yet. We sweep new filings monthly.